Navigation Links
AquaStar Holdings, Inc. Subsidiary Appoints Former Beckman Coulter Executive as Vice President of Operations

SANTA ANA, Calif., June 3, 2011 /PRNewswire/ -- AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company's wholly-owned subsidiary, SUTIMCo, Inc., has retained the services of Mr. Ed Ellsworth as Vice President of Business Development.  Mr. Ellsworth will assist with the development and positioning of the numerous University conceived technologies that SUTIMCo manages. Mr. Ellsworth, who comes to SUTIMCo straight from Beckman Coulter (NYSE: BEC), will be immediately tasked with the development of the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform technology.

Mr. Ellsworth brings more than 20 years experience in the diagnostic and life science industry with a focus on commercializing and advancing technology across the life science continuum. Mr. Ellsworth has numerous years with Beckman Coulter, a leader in the Biotechnology Industry with over $3.7 billion in revenue for 2010, where most recently he was responsible for operational marketing and business management of the immunochemistry, hematology, chemistry and rapid diagnostic testing products for the channel business. In addition, Mr. Ellsworth directed the distributor partnership corporate accounts group delivering over $100 million in revenue.

"SUTIMCo is in the forefront of bringing exciting new technologies to market.  I'm delighted to be on the team and I look forward to working with SUTIMCo management," stated Ed Ellsworth, Vice President of Business Development of SUTIMCo, Inc.

"Ed's appointment further deepens our understanding of the diagnostic and life science industry and will be a tremendous contribution as we develop our client companies," stated Malcolm Lennie, President of AquaStar Holdings, Inc. "He comes with extensive, real-life understanding of technology commercialization that will be a valuable asset to the Company."

For more information on SUTIMCo, its portfolio companies, and University partners, please visit;

About AquaStar Holdings, Inc.:

AquaStar Holdings, Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. AquaStar Holdings, through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, AquaStar Holdings can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results

Investor Relations

SOURCE AquaStar Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
2. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
3. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
5. China Pharma Holdings, Inc. Appoints The Ruth Group
6. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
7. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
8. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
10. JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media
11. EFT BioTech Holdings, Inc.s Subsidiary Receives First Permit to Cross Taiwan Strait
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... of the year and one of the premier annual events for pharmaceutical manufacturing: ... from 8–11 November 2015, where ISPE hosted the largest number of attendees in ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
Breaking Biology News(10 mins):